Acute phase protein levels in dogs with mast cell tumours and sarcomas

Veterinary Record

Volumn 170, Issue 25, 2012, Pages 648-

  Chase, D ^a   McLauchlan, G ^b   Eckersall, P D ^b   Pratschke, J ^b   Parkin, T ^b   Pratschke, K ^c  

^a PRIDE VETERINARY CENTRE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

EID: 84862899643     PISSN: 00424900     EISSN: None     Source Type: Journal    
DOI: 10.1136/vr.100401     Document Type: Article

References (60)

1. ANDERSSON, M., STENSTRÖM, M., VATNE, M., SEVELIUS, E. & JÖNSSON, L. (1998) Disease-related variations of the glycosylation of haptoglobin in the dog. Journal of Comparative Pathology 119, 227-238 (Pubitemid 28482934)
2. ANDERSSEN, M. & SIVELIUS, E. (2001) Abnormal microheterogeneity of haptoglobin in serum from dogs with various diseases. Veterinary Record 148, 14-17
3. ASAO, T., KUWANO, H., NAKAMURA, J., OKAMURA, A., BERGER, E. G., MATTA, K. L. & YAZAWA, S. (2000) Tumour cells as the origin of elevated serum alpha 1, 3 fucosyltransferase in association with malignancy. Clinical and Experimental Metastasis 18, 605-610 (Pubitemid 32964323)
4. BERGHELLA, A. M., PELLEGRINI, P., DEL BEATO, T., MARINI, M., TOMEI, E., ADORNO, D. & CASCIANI, C. U. (1998) The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 to TH2 and back. Cancer Immunology, Immunotherapy 45, 241-249 (Pubitemid 128759558)
5. BEER, T. M., LALANI, A. S., LEE, S., MORI, M., EILERS, K. M., CURD, J. G., HENNER, W. D., RYAN, C. W., VENNER, P., RUETHER, J. D. & CHI, K. N. (2008) C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial. Cancer 112, 2377-2383
6. BIRAN, H., FRIEDMAN, N., NEUMANN, L., PRAS, M. & SHAINKIN-KESTENBAUM, R. (1986) Serum amyloid A (SAA) variations in patients with cancer: correlation with disease activity, stage, primary site, and prognosis. Journal of Clinical Pathology 39, 794-797 (Pubitemid 16069491)
7. BLAY, J. Y., BURDIN, N., ROUSSET, F., LENOIR, G., BIRON, P., PHILIP, T., BANCHEREAU, J. & FAVROT, M. C. (1993) Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood 82, 2169-2174 (Pubitemid 23294002)
8. BOLAYIRLI, M., TURNA, H., ORHANOGLU, T., OZARAS, R., ILHAN, M. & OZGÜROGLU, M. (2007) C-reactive protein as an acute phase protein in cancer patients. Medical Oncology (Northwood, London, England) 24, 338-344 (Pubitemid 350135957)
9. CANNA, K., MCMILLAN, D. C., MCKEE, R. F., MCNICOL, A. M., HORGAN, P. G. & MCARDLE, C. S. (2004) Evaluation of a cumulative prognostic score based on the systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer. British Journal of Cancer 90, 1707-1709 (Pubitemid 38725638)
10. CASAMASSIMA, A., PICCIARIELLO, M., QUARANTA, M., BERARDINO, R., RANIERI, C., PARADISO, A., LORUSSO, V. & GUIDA, M. (2005) C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy. Journal of Urology 173, 52-55 (Pubitemid 39627670)
11. CERON, J. J., ECKERSALL, P. D. & MARTNEZ-SUBIELA, S. (2005) Acute phase proteins in dogs and cats: current knowledge and future perspectives. Veterinary Clinical Pathology/American Society for Veterinary Clinical Pathology 34, 85-99 (Pubitemid 40799488)
12. CHAN, D. C., CHEN, C. J., CHU, H. C., CHANG, W. K., YU, J. C., CHEN, Y. J., WEN, L. L., HUANG, S. C., KU, C. H., LIU, Y. C. & CHEN, J. H. (2007) Evaluation of serum amyloid A as a biomarker for gastric cancer. Annals of Surgical Oncology 14, 84-93
13. CHING-CHIH, L., HSU-CHUEH, H., MOON-SING, L., SHIH-KAI, H., CHIH-CHIA, Y. & YU-CHIEH, S. (2010) Expression of haptoglobin predicts recurrence in head and neck squamous cell carcinoma. Clinica Chimica Acta 411, 1116-1121
14. CHUNG, Y. C. & CHANG, Y. F. (2003) Serum C-reactive protein correlates with survival in colorectal cancer patients but is not an independent prognostic indicator. European Journal of Gastroenterology & Hepatology 15, 369-373
15. CROCE, M. V., SÁLICE, V. C., LACUNZA, E. & SEGAL-EIRAS, A. (2005) Alpha 1-acid glycoprotein (AGP): a possible carrier of sialyl lewis X (slewis X) antigen in colorectal carcinoma. Histology and Histopathology 20, 91-97 (Pubitemid 40028987)
16. CROZIER, J. E., MCKEE, R. F., MCARDLE, C. S., ANGERSON, W. J., ANDERSON, J. H., HORGAN, P. G. & MCMILLAN, D. C. (2006) The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer. British Journal of Cancer 94, 1833-1836 (Pubitemid 43882573)
17. DENNIS, M. M., MCSPORRAN, K. D., BACON, N. J., SCHULMAN, F. Y., FOSTER, R. A. & POWERS, B. E. (2011) Prognostic factors for cutaneous and subcutaneous soft tissue sarcomas in dogs. Veterinary Pathology 48, 73-84
18. DUTHIE, S., ECKERSALL, P. D., ADDIE, D. D., LAWRENCE, C. E. & JARRETT, O. (1997) Value of alpha 1-acid glycoprotein in the diagnosis of feline infectious peritonitis. Veterinary Record 141, 299-303 (Pubitemid 127491376)
19. ECKERSALL, P. D. & BELL, R. (2010) Acute phase proteins: Biomarkers of infection and inflammation in veterinary medicine. Veterinary Journal 185, 23-27
20. EL-GHMATI, S. M., ARREDOUANI, M., VAN HOEYVELD, E. M., CEUPPENS, J. L. & STEVENS, E. A. (2002) Haptoglobin interacts with the human mast cell line HMC-1 and inhibits its spontaneous proliferation. Scandinavian Journal of Immunology 55, 352-358 (Pubitemid 34429790)
21. ELG, S. A., MAYER, A. R., CARSON, L. F., TWIGGS, L. B., HILL, R. B. & RAMAKRISHNAN, S. (1997) Alpha-1 acid glycoprotein is an immunosuppressive factor found in ascites from ovaria carcinoma. Cancer 80, 1448-1456 (Pubitemid 27441019)
22. FRANSSON, B. A., KARLSTAM, E., BERGSTROM, A., LAGERSTEDT, A. S., PARK, J. S., EVANS, M. A. & RAGLE, C. A. (2004) C-reactive protein in the differentiation of pyometra from cystic endometrial hyperplasia/mucometra in dogs. Journal of the American Animal Hospital Association 40, 391-399 (Pubitemid 43180237)
23. FUJIMOTO, T., SATO, Y., SASAKI, N., TESHIMA, R., HANAOKA, K. & KITANI, S. (2003) The canine mast cell activation via CRP. Biochemical and Biophysical Research Communications 301, 212-217 (Pubitemid 36268869)
24. GUNTER, M. J., STOLZENBERG-SOLOMON, R., CROSS, A. J., LEITZMANN, M. F., WEINSTEIN, S., WOOD, R. J., VIRTAMO, J., TAYLOR, P. R., ALBANES, D. & SINHA, R. (2006) A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Research 66, 2483-2487
25. GUTFELD, O., PRUS, D., ACKERMAN, Z., DISHON, S., LINKE, R. P., LEVIN, M. & URIELI-SHOVAL, S. (2006) Expression of serum amyloid A, in normal, dysplastic, and neoplastic human colonic mucosa: implication for a role in colonic tumorigenesis. Journal of Histochemistry and Cytochemistry 54, 63-73 (Pubitemid 43049416)
26. HASHIMOTO, S., ASAO, T., TAKAHASHI, J., YAGIHASHI, Y., NISHIMURA, T., SANIABADI, A. R., POLAND, D. C., VAN DIJK, W., KUWANO, H., KOCHIBE, N. & YAZAWA, S. (2004) alpha1-acid glycoprotein fucosylation as a marker of carcinoma progression and prognosis. Cancer 101, 2825-2836 (Pubitemid 39603191)
27. ITOH, H., HORIUCHI, Y., NAGASAKI, T., SAKONJU, I., KAKUTA, T., FUKUSHIMA, U., UCHIDE, T., YAMASHITA, M., KUWABARA, M., YUSA, S. & TAKASE, K. (2009) Evaluation of immunological status in tumor-bearing dogs. Veterinary Immunology and Immunopathology 132, 85-90
28. JERGENS, A. E., SCHREINER, C. A., FRANK, D. E., NIYO, Y., AHRENS, F. E., ECKERSALL, P. D., BENSON, T. J. & EVANS, R. (2003) A scoring index for disease activity in canine inflammatory bowel disease. Journal of Veterinary Internal Medicine/American College of Veterinary Internal Medicine 17, 291-297 (Pubitemid 37465328)
29. KISHI, A., OHMORI, M., TOMITA, S., UNO, K. & TANIGAWA, M. (1999) Phenotypic and functional analyses of natural killer cells: impaired NK activity partly due to the CD56+ cell dysfunction in cancer patients. International Journal of Immunotherapy 15, 1-12 (Pubitemid 29363955)
30. KOIKE, Y., MIKI, C., OKUGAWA, Y., YOKOE, T., TOIYAMA, Y., TANAKA, K., INOUE, Y. & KUSUNOKI, M. (2008) Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer. Journal of Surgical Oncology 98, 540-544
31. KUMAR, D. M., THOTA, B., SHINDE, S. V., PRASANNA, K. V., HEGDE, A. S., ARIVAZHAGAN, A., CHANDRAMOULI, B. A., SANTOSH, V. & SOMASUNDARAM, K. (2010) Proteomic identification of haptoglobin a2 as a glioblastoma serum biomarker: implications in cancer cell migration and tumor growth. Journal of Proteome Research 9, 5557-5567
32. LOWRIE, M., PENDERIS, J., ECKERSALL, P. D., MCLAUGHLIN, M., MELLOR, D. & ANDERSON, T. J. (2009a) The role of acute phase proteins in diagnosis and management of steroid-responsive meningitis arteritis in dogs. Veterinary Journal 182, 125-130
33. LOWRIE, M., PENDERIS, J., MCLAUGHLIN, M., ECKERSALL, P. D. & ANDERSON, T. J. (2009b) Steroid responsive meningitis-arteritis: a prospective study of potential disease markers, prednisolone treatment, and long-term outcome in 20 dogs (2006-2008). Journal of Veterinary Internal Medicine 23, 862-870
34. MCMILLAN, D. C., CANNA, K. & MCARDLE, C. S. (2003) Systemic inflammatory response predicts survival following curative resection for colorectal cancer. British Journal of Surgery 90, 215-219 (Pubitemid 36237897)
35. MA, J., GIOVANNUCCI, E., POLLAK, M., LEAVITT, A., TAO, Y., GAZIANO, J. M. & STAMPFER, M. J. (2004) A prospective study of plasma C-peptide and colorectal cancer risk in men. Journal of the National Cancer Institute 96, 546-553 (Pubitemid 38559579)
36. MALLE, E., SODIN-SEMRL, S. & KOVACEVIC, A. (2009) Serum amyloid A: an acutephase protein involved in tumour pathogenesis. Cellular and Molecular Life Sciences 66, 9-26
37. MERLO, A., GAGLIANO REZENDE, B. C., MARIA LUISA, F., NUNES SIMÕES, D. M. & RICCI LUCAS, S. R. (2007) Serum C-reactive protein concentrations in dogs with multicentric lymphoma undergoing chemotherapy. Journal of the American Veterinary Medical Association 230, 522-526 (Pubitemid 46391444)
38. MISCHKE, R., WATERSTON, M. & ECKERSALL, P. D. (2007) Changes in C-reactive protein and haptoglobin in dogs with lymphatic neoplasia. Veterinary Journal 174, 188-192 (Pubitemid 46865748)
39. MIYOSHI, E., SHINZAKI, S., MORIWAKI, K. & MATSUMOTO, H. (2010) Identification of fucosylated haptoglobin as a novel tumor marker for pancreatic cancer and its possible application for a clinical diagnostic test. Methods in Enzymology 478, 153-164
40. MORRIS-STIFF, G., GOMEZ, D. & PRASAD, K. R. (2008) C-reactive protein in liver cancer surgery. European Journal of Surgical Oncology 34, 727-729
41. MURATA, H., SHIMADA, N. & YOSHIOKA, M. (2004) Current research on acute phase proteins in veterinary diagnosis: an overview. Veterinary Journal 168, 28-40 (Pubitemid 38684202)
42. NAKAMURA, M., TAKAHASHI, M., OHNO, K., KOSHINO, A., NAKASHIMA, K., SETOGUCHI, A., FUJINO, Y. & TSUJIMOTO, H. (2008) C-reactive protein concentration in dogs with various diseases. Journal of Veterinary Medical Science 70, 127-131 (Pubitemid 351366443)
43. NIELSEN, L., TOFT, N., ECKERSALL, P. D., MELLOR, D. J. & MORRIS, J. S. (2007) Serum C-reactive protein concentration as an indicator of remission status in dogs with multicentric lymphoma. Journal of Veterinary Internal Medicine/American College of Veterinary Internal Medicine 21, 1231-1236 (Pubitemid 350303627)
44. NOZOE, T., MATSUMATA, T., KITAMURA, M. & SUGIMACHI, K. (1998) Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. American Journal of Surgery 176, 335-338 (Pubitemid 28514444)
45. NOZOE, T., MATSUMATA, T. & SUGIMACHI, K. (2000) Preoperative elevation of serum C-reactive protein is related to impaired immunity in patients with colorectal cancer. American Journal of Clinical Oncology 23, 263-266 (Pubitemid 32428031)
46. NOZOE, T., KORENAGA, D., FUTATSUGI, M., SAEKI, H., MAEHARA, Y. & SUGIMACHI, K. (2003) Immunohistochemical expression of C-reactive protein in squamous cell carcinoma of the esophagus - significance as a tumor marker. Cancer Letters 192, 89-95 (Pubitemid 36287664)
47. OKA, M., INABA, A., UCHIYAMA, T., HAZAMA, S., SHIMODA, K., SUZUKI, M. & SUZUKI, T. (1994) Prostaglandin E2 levels and lymphocyte subsets in portal venous drainage of colorectal cancers. American Journal of Surgery 167, 264-267
48. OKA, M., HIROSE, K., IIZUKA, N., AOYAGI, K., YAMAMOTO, K., ABE, T., HAZAMA, S. & SUZUKI, T. (1995) Cytokine mRNA expression patterns in human esophageal cancer cell lines. Journal of Interferon & Cytokine Research 15, 1005-1009
49. OKA, M., YAMAMOTO, K., TAKAHASHI, M., HAKOZAKI, M., ABE, T. & IIZUKA, N. (1996) Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma. Cancer Research 56, 2776-2780 (Pubitemid 26175737)
50. PATNAIK, A. K., EHLER, W. J. & MACEWEN, E. G. (1984) Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Veterinary Pathology 21, 469-474
51. PLANELLAS, M., BASSOLS, A., SIRACUSA, C., SACO, Y., GIMÉNEZ, M., PATO, R. & PASTOR, J. (2009) Evaluation of serum haptoglobin and C-reactive protein in dogs with mammary tumors. Veterinary Clinical Pathology/American Society for Veterinary Clinical Pathology 38, 348-352
52. RAMANKULOV, A., LEIN, M., JOHANNSEN, M., SCHRADER, M., MILLER, K., LOENING, S. A. & JUNG, K. (2008) Serum amyloid A as indicator of distant metastases but not as early tumor marker in patients with renal cell carcinoma. Cancer Letters 269, 85-92
53. SELTING, K. A., OGILVIE, G. K., LANA, S. E., FETTMAN, M. J., MITCHENER, K. L., HANSEN, R. A., RICHARDSON, K. L., WALTON, J. A. & SCHERK, M. A. (2000) Serum alpha 1-acid glycoprotein concentrations in healthy and tumor-bearing cats. Journal of Veterinary Internal Medicine 14, 503-506
54. TAKIUCHI, H., TADA, T., LI, X. F., OGATA, M., IKEDA, T., FUJIMOTO, S., FUJIWARA, H. & HAMAOKA, T. (1992) Particular types of tumor cells have the capacity to convert transforming growth factor beta from a latent to an active form. Cancer Research 52, 5641-5646
55. TECLES, F., SPIRANELLI, E., BONFANTI, U., CERÓN, J. J. & PALTRINIERI, S. (2005) Preliminary studies of serum acute-phase protein concentrations in hematologic and neoplastic diseases of the dog. Journal of Veterinary Internal Medicine/American College of Veterinary Internal Medicine 19, 865-870 (Pubitemid 41736996)
56. TECLES, F., CALDÍN, M., ZANELLA, A., MEMBIELA, F., TVARIJONAVICIUTE, A., SUBIELA, S. M. & CERÓN, J. J. (2009) Serum acute phase protein concentrations in female dogs with mammary tumors. Journal of Veterinary Diagnostic Investigation 21, 214-219
57. URIELI-SHOVAL, S., COHEN, P., EISENBERG, S. & MATZNER, Y. (1998) Widespread expression of serum amyloid A in histologically normal human tissues: predominant localization to the epithelium. Journal of Histochemistry and Cytochemistry 46, 1377-1384 (Pubitemid 28555406)
58. SHEAHAN, D., BELL, R., MELLANBY, R. J., GOW, A. G., FRIEND, E., HELLER, J., BENCE, L. M. & ECKERSALL, P. D. (2010) Acute phase protein concentrations in dogs with nasal disease. Veterinary Record 167, 895-899
59. YUKI, M., ITOH, H. & TAKASE, K. (2010) Serum a-1-acid glycoprotein concentration in clinically healthy puppies and adult dogs and in dogs with various diseases. Veterinary Clinical Pathology 39, 65-71
60. YUKI, M., MACHIDA, N., SAWANO, T. & ITOH, H. (2011) Investigation of serum concentrations and immunohistochemical localization of a1-acid glycoprotein in tumor dogs. Veterinary Research Communications 35, 1-11